Moderna Inc (MRNA) Stock: How Does it Score?

Monday, November 16, 2020 11:41 AM | InvestorsObserver Analysts

Moderna Inc (MRNA) stock has risen 390.90% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives MRNA stock a score of 66 out of a possible 100.

That rank is primarily influenced by a long-term technical score of 96. MRNA's rank also includes a short-term technical score of 89. The fundamental score for MRNA is 12. In addition to the average rating from Wall Street analysts, MRNA stock has a mean target price of 89.583. This means analysts expect the stock to lose 6.18% over the next 12 months.

Overall Score - 66
MRNA has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on MRNA!

What's Happening with MRNA Stock Today

Moderna Inc (MRNA) stock has gained 6.81% while the S&P 500 has risen 1.13% as of 11:38 AM on Monday, Nov 16. MRNA has risen $6.09 from the previous closing price of $89.39 on volume of 44,694,031 shares. Over the past year the S&P 500 has risen 16.14% while MRNA has risen 390.90%. MRNA lost -$1.62 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Moderna Inc (MRNA) Stock.

Share this article:

Related Companies

You May Also Like

Related Articles

Sector Update: Health Care

Midday Report: US Stocks Mixed as Investors Digest Large-Cap Earnings

European Stocks Improve Tuesday; IMF Cuts 2021 Growth Estimates for Euro Area

Where Will Beigene Ltd (BGNE) Stock Go Next After It Is Up 2.03% in a Week?

How Will the Market React to GlycoMimetics Inc (GLYC) Stock Getting a Bullish Rating

Related Companies